Role of expression of atrial natriuretic peptide gene in essential hypertension among Egyptian patients

References

• Canale MP, Noce A, Di Lauro M, et al. Gut dysbiosis and western diet in the pathogenesis of essential arterial hypertension: a narrative review. Nutrients. 2021;13(4). DOI:https://doi.org/10.3390/nu13041162.
   Google Scholar
• Ghatage T, Goyal SG, Dhar A, et al. Novel therapeutics for the treatment of hypertension and its associated complications: peptide- and nonpeptide-based strategies. Hypertens Res. 2021;44(7):740–755.
   Web of Science ®Google Scholar
• Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–237.
   PubMed Web of Science ®Google Scholar
• Bolívar JJ. Essential hypertension: an approach to its etiology and neurogenic pathophysiology. Int J Hypertens. 2013;2013:547809.
   Google Scholar
• Charles L, Triscott J, Dobbs B. Secondary hypertension: discovering the underlying cause. Am Fam Physician. 2017;96(7):453–461.
   PubMed Web of Science ®Google Scholar
• Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75(2):285–292.
   PubMed Web of Science ®Google Scholar
• Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–1913.
   PubMed Web of Science ®Google Scholar
• Williams RR, Hunt SC, Hasstedt SJ, et al. Current knowledge regarding the genetics of human hypertension. J Hypertens Suppl. 1989;7(6):S8–13.
   Google Scholar
• Oparil S, Acelajado MC, Bakris GL, et al. Hypertension. Nat Rev Dis Primers. 2018;4:18014.
   PubMed Web of Science ®Google Scholar
• Reisin E, Messerli FH. Obesity-related hypertension: mechanisms, cardiovascular risks, and heredity. Curr Opin Nephrol Hypertens. 1995;4(1):67–71.
   Google Scholar
• Rocchini AP, Moorehead CP, DeRemer S, et al. Pathogenesis of weight-related changes in blood pressure in dogs. Hypertension. 1989;13(6 Pt 2):922–928.
   Web of Science ®Google Scholar
• Rocchini AP. Insulin resistance and blood pressure regulation in obese and nonobese subjects. Special lecture. Hypertension. 1991;17(6 Pt 2):837–842.
   Web of Science ®Google Scholar
• Rocchini AP, Key J, Bondie D, et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med. 1989;321(9):580–585.
   Web of Science ®Google Scholar
• Hall JE, Do Carmo JM, da Silva AA, et al. Obesity, kidney dysfunction and hypertension: mechanistic links. Nat Rev Nephrol. 2019;15(6):367–385.
   PubMed Web of Science ®Google Scholar
• Paz Ocaranza M, Riquelme JA, García L, et al. Counter-regulatory renin-angiotensin system in cardiovascular disease. Nat Rev Cardiol. 2020;17(2):116–129.
   PubMedGoogle Scholar
• Poch E, González D, Giner V, et al. Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension. 2001;38(5):1204–1209.
   PubMed Web of Science ®Google Scholar
• Oparil S, Schmieder RE. New approaches in the treatment of hypertension. Circ Res. 2015;116(6):1074–1095.
   PubMed Web of Science ®Google Scholar
• Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 2007;292(1):C82–97.
   PubMed Web of Science ®Google Scholar
• Kumar U, Wettersten N, Garimella PS. Cardiorenal syndrome: pathophysiology. Cardiol Clin. 2019;37(3):251–265.
   Web of Science ®Google Scholar
• Nguyen Q, Dominguez J, Nguyen L, et al. Hypertension management: an update. Am Health Drug Benefits. 2010;3(1):47–56.
   PubMedGoogle Scholar
• Chandra S, Saluja D, Narang R, et al. Atrial natriuretic peptide and aldosterone synthase gene in essential hypertension: a case-control study. Gene. 2015;567(1):92–97.
   Web of Science ®Google Scholar
• Pandey KN. Molecular and genetic aspects of guanylyl cyclase natriuretic peptide receptor-A in regulation of blood pressure and renal function. Physiol Genomics. 2018;50(11):913–928.
   Web of Science ®Google Scholar
• Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339(5):321–328.
   PubMed Web of Science ®Google Scholar
• Dzau VJ, Baxter JD, Cantin M, et al. Nomenclature for atrial peptides. N Engl J Med. 1987;316(20):1278–1279.
   Web of Science ®Google Scholar
• Goetze JP, Bruneau BG, Ramos HR, et al. Cardiac natriuretic peptides. Nat Rev Cardiol. 2020;17(11):698–717.
   Web of Science ®Google Scholar
• Ichiki T, Huntley BK, Heublein DM, et al. Corin is present in the normal human heart, kidney, and blood, with Pro–B-Type natriuretic peptide processing in the circulation. Clin Chem. 2011;57(1):40–47.
   Web of Science ®Google Scholar
• Yan W, Wu F, Morser J, et al. Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. Proc Nat Acad Sci. 2000;97(15):8525–8529.
   PubMed Web of Science ®Google Scholar
• Misono KS, Philo JS, Arakawa T, et al. Structure, signaling mechanism and regulation of the natriuretic peptide receptor guanylate cyclase. FEBS J. 2011;278(11):1818–1829.
   Web of Science ®Google Scholar
• Pandey KN. Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca2+ release, and activation of protein kinase C. Front Mol Neurosci. 2014;7:75.
   Web of Science ®Google Scholar
• Potter LR, Yoder AR, and Flora DR, et al. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol. 2009;(191):341–366 doi: https://doi.org/10.1007/978-3-540-68964-5_15. PMID: 19089336; PMCID: PMC4855512. doi: https://doi.org/10.1007/978-3-540-68964-5_15. PMID: 19089336; PMCID: PMC4855512.
   Google Scholar
• Nose H, Takamata A, Mack GW, et al. Right atrial pressure and ANP release during prolonged exercise in a hot environment. J Appl Physiol (1985). 1994;76(5):1882–1887.
   Web of Science ®Google Scholar
• Yan W, Sheng N, Seto M, et al. Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. J Biol Chem. 1999;274(21):14926–14935.
   PubMed Web of Science ®Google Scholar
• Kessler-Icekson G, Barhum Y, Schaper J, et al. ANP expression in the hypertensive heart. Exp Clin Cardiol. 2002;7(2–3):80–84.
   Google Scholar
• Rubattu S, Bigatti G, Evangelista A, et al. Association of atrial natriuretic peptide and type A natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol. 2006;48(3):499–505.
   Web of Science ®Google Scholar
• Carretero OA, Oparil S. Essential hypertension. Circulation. 2000;101(3):329–335.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Kiemer AK, Fürst R, Vollmar AM. Vasoprotective actions of the atrial natriuretic peptide. Curr Med Chem Cardiovasc Hematol Agents. 2005;3(1):11–21.
   Google Scholar
• Chen H, Levine YC, Golan DE, et al. Atrial natriuretic peptide-initiated cGMP pathways regulate vasodilator-stimulated phosphoprotein phosphorylation and angiogenesis in vascular endothelium. J Biol Chem. 2008;283(7):4439–4447.
   Web of Science ®Google Scholar
• John SW, Krege JH, Oliver PM, et al. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science. 1995;267(5198):679–681.
   PubMed Web of Science ®Google Scholar
• Dessì-Fulgheri P, Sarzani R, Tamburrini P, et al. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J Hypertens. 1997;15(12 Pt 2):1695–1699.
   Web of Science ®Google Scholar
• Kaganovsky E, Belkin V, Barhum Y, et al. Occurrence and distribution of atrial natriuretic peptide-containing cells in the left ventricle of hypertensive rats. Effect of antihypertensive treatment. Cell Tissue Res. 2001;303(1):57–67.
   Web of Science ®Google Scholar
• Wang TJ, Larson MG, Levy D, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004;109(5):594–600.
   PubMed Web of Science ®Google Scholar
• Gopi V, Parthasarathy A, Umadevi S, et al. Angiotensin-II down-regulates cardiac natriuretic peptide receptor-A mediated anti-hypertrophic signaling in experimental rat hearts. Indian J Exp Biol. 2013;51(1):48–55.
   PubMed Web of Science ®Google Scholar
• Arendse LB, Danser AHJ, Poglitsch M, et al. Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure. Pharmacol Rev. 2019;71(4):539–570.
   PubMed Web of Science ®Google Scholar
• Uijl E, Mirabito Colafella KM, Sun Y, et al. Strong and sustained antihypertensive effect of small interfering RNA targeting liver angiotensinogen. Hypertension. 2019;73(6):1249–1257.
   Web of Science ®Google Scholar
• Ghodsian N, Ismail P, Ahmadloo S, et al. Genetic analysis of the atrial natriuretic peptide gene polymorphisms among essential hypertensive patients in Malaysia. Biomed Res Int. 2016;2016:6712529.
   Web of Science ®Google Scholar
• Pinheiro DS, Santos RS, Jardim P, et al. The combination of ACE I/D and ACE2 G8790A polymorphisms revels susceptibility to hypertension: a genetic association study in Brazilian patients. PLoS One. 2019;14(8):e0221248.
   PubMed Web of Science ®Google Scholar
• Arise KK, Kumar P, Garg R, et al. Angiotensin II represses Npr1 expression and receptor function by recruitment of transcription factors CREB and HSF-4a and activation of HDACs. Sci Rep. 2020;10(1):4337.
   Web of Science ®Google Scholar